• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Fact or fiction? COVID-19 myths and controversies

Article

An "info-demic" has muddied the waters of what is true and what is false about COVID-19. A new webinar from MJH Life Sciences can clinicians sort through fact and fiction.

The news about COVID-19 has been coming fast and seems to change some facet of the disease nearly every day. Unfortunately, some of that news is either false, like hydroxychloroquine is the cure for COVID-19, or the science catches up, such as children always have low-risk cases of COVID-19. The oversaturation of information has been another epidemic running alongside the pandemic.

To combat this “info-demic,” the MJH Life Science’s COVID-19 Coalition is presenting the “Fact or Fiction? COVID-19 Myths and Controversies” webinar on September 29, 2020, at 6 PM, eastern. The webinar will be moderated by Saskia V. Popescu, PhD, MPH, MA, CIC, a term assistant professor at George Mason University and an adjunct professor at the University of Arizona College of Public Health. She will be joined by Angela Rasmussen, PhD, an associate research scientist at the Columbia University Mailman School of Public Health, as well as Emily Ricotta, PhD, MSc, a research fellow in the Epidemiology Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

To register for webinar, click here.

Related Videos
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
© 2024 MJH Life Sciences

All rights reserved.